Halaven (eribulin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Halaven (eribulin), covering 2015-10-27 to 2015-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination [Phase 1]